Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Empower Clinics subsidiary MediSure enters pilot with Care Group of Pharmacies to carry leading diabetes management medical devices

"We only recently completed the acquisition of Medisure, and with additional resources and access to our pharmacy network, the MediSure team are securing new opportunities that provide immediate increased shelf-space, new orders and increas

Empower Clinics Inc said its wholly-owned subsidiary Medi+Sure Canada Inc has entered into a pilot agreement with the Care Group of Pharmacies to carry MediSure diabetes management medical devices in their pharmacies.

The integrated healthcare company said the products include MediSure’s best-in-class blood glucose monitoring (BGM) products, test strips and other items that positively impact the daily lives of many Canadians.

Empower noted that one in four Canadians suffer from pre-diabetes or type I and type II diabetes, resulting in a medical crisis that is worsening. According to Statistics Canada, on average, 549 Canadians are diagnosed with diabetes each day, and 11% of Canadian adults aged 20+ are currently living with diabetes.

READ: Empower Clinics' MediSure gets Health Canada Medical Device Establishment Licence to source medical devices globally

"We only recently completed the acquisition of Medisure, and with additional resources and access to our pharmacy network, the MediSure team are securing new opportunities that provide immediate increased shelf-space, new orders and increased revenue,” Empower chairman and CEO Steven McAuley said in a statement.

"By working with Care Group, we are connecting sought-after diabetic management products with a robust network of independent pharmacists from coast to coast. This is only the beginning of what I expect to be a wonderful relationship focused on elevating the frontline care provided by Care Group pharmacists,” he added.

Empower Clinics said the objective of the pilot program is to provide diabetes management solutions to Care Group through their independent pharmacy platform for resale and distribution to their independent pharmacy partners.

The program will evaluate costs and revenue opportunities to best determine the final business model that will serve Care Group patients and their corporate accounts. The parties will evaluate the complete program with the objective to enter into a definitive agreement for a nationwide rollout.

Care Group is one of Canada's fastest-growing pharmacy groups with numerous locations across six provinces. Its independent pharmacy model blends local healthcare operations with industry-leading resources that ensure the best in quality patient services. Empower will provide Health Canada-approved MediSure diabetes management solutions, express shipping on all ordered units and technical support.

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories.

It is aggressively growing its clinical and digital presence across North America.

Empower’s Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of its patients.

Contact the author at stephen.gunnion@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK